Farnesyl transferase inhibitor SCH66336 is cytostatic, pro‐apoptotic and enhances chemosensitivity to cisplatin in melanoma cells
Keiran S.M. Smalley(Moffitt Cancer Center), Tim Eisen
Cited by 94
Related Papers
PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
|Cancer Research|2011|546
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
|British Journal of Cancer|2010|313
Dysregulation of Claudin-7 Leads to Loss of E-Cadherin Expression and the Increased Invasion of Esophageal Squamous Cell Carcinoma Cells
|American Journal Of Pathology|2007|134
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
|British Journal of Cancer|2007|105